Thyroid Cancer, Medullary
5 clinical trials · Condition
◉ Watch Thyroid Cancer, Medullary
| Record | Firm | Date |
|---|---|---|
| Evaluation of the 18F-PSMA Positron Emission Tomography (PET)/CT in Patients With Medullary Thyroid Cancer (NCT05534594) | University Medical Center Groningen | 2022-08-19 |
| 177Lu-PP-F11N in Combination With Sacubitril for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer (NCT03647657) | University Hospital, Basel, Switzerland | 2018-12-13 |
| Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer (NCT03630120) | H. Lee Moffitt Cancer Center and Research Institute | 2018-08-06 |
| 177Lu-PP-F11N for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer. (NCT02088645) | University Hospital, Basel, Switzerland | 2015-04-01 |
| 18F-FDOPA PET in Neuroendocrine Tumours (NCT02431715) | British Columbia Cancer Agency |
Track Thyroid Cancer, Medullary automatically
Every clearance here is in the API, with alerts when new ones post.